Drawing for KEMWELL

USPTO serial 79126182

KEMWELL

Reviewed by CopyMark Law Group

Reg. 4473063Status 404
Filing date
Status date
Registration date
Jan 28, 2014
Examiner
TURNER, JASON FITZGERALD
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KEMWELL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Leonard

Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Building 3Lawrenceville, NJ 08648-2311UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science, namely, diagnostic preparations for scientific and research use, chemical reagents for non-medical purposes, diagnostic preparations for clinical or medical laboratory use, diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; chemicals for use in the pharmaceutical industry; chemical substances for use in the biochemical industry; biological preparation for use in cell cultures other than for medical or veterinary useSECTION 71 - CANCELLED—
005[ Pharmaceuticals, namely, anti-infectives, antibiotics, antifungal preparations, antivirals; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for medical purposes; antiallergic medicines for human purposes; sanitary preparations for medical purposes; sterile saline solutions for medical purposes ]SECTION 7(e) - CANCELLED—
016Paper; printed matter, namely, curricula in the field of pharmaceuticals; publications, namely, brochures and booklets featuring promotional advertisements for the goods of others; educational publications, namely, training manuals in the fields of laboratory and medical research and pharmaceuticals; printed publications namely magazines in the fields of pharmaceuticals and medical research); visiting cards; non-apparatus printed instructional and teaching materialSECTION 71 - CANCELLED—
035Advertising, marketing and promotion services; business management; business operation, business administration and office functions; compilation of statistical data relating to medical researchSECTION 71 - CANCELLED—
042Scientific and technological services, namely, scientific, biological, pharmaceutical and medical research services, laboratory research in the field of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; chemical, biochemical and biotechnological analysis; design and development of computer hardware and software; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development servicesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 8, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
May 8, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 6, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 1, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jan 31, 2022INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Jan 28, 2019REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 8, 2017INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 9, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 12, 2016TRPPREQUEST FOR TRANSFORMATION PROCESSED - PARTIAL—
Jun 28, 2016ERFTTEAS REQUEST FOR TRANSFORMATION RECEIVED—
May 9, 2016LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
May 9, 2016COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 9, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 5, 2016LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 4, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 16, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 16, 2014FIMPFINAL DISPOSITION PROCESSED—
Apr 28, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 28, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 12, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 12, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 10, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 10, 2013ALIEASSIGNED TO LIE—
Sep 27, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 6, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 5, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 5, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2013RFNTREFUSAL PROCESSED BY IB—
Mar 13, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 13, 2013RFRRREFUSAL PROCESSED BY MPU—
Mar 12, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 12, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 12, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 12, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 10, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 9, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 8, 2013DOCKASSIGNED TO EXAMINER—
Mar 8, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 7, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance